ICL Israel Chemicals Ltd (ICL) - Total Liabilities
Based on the latest financial reports, ICL Israel Chemicals Ltd (ICL) has total liabilities worth ILA6.17 Billion ILA (≈ $16.54 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ICL net asset momentum to track the company's year-over-year net asset growth rate.
ICL Israel Chemicals Ltd - Total Liabilities Trend (2000–2025)
This chart illustrates how ICL Israel Chemicals Ltd's total liabilities have evolved over time, based on quarterly financial data. See ICL Israel Chemicals Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
ICL Israel Chemicals Ltd Competitors by Total Liabilities
The table below lists competitors of ICL Israel Chemicals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AMMB Holdings Bhd
KLSE:1015
|
Malaysia | RM185.74 Billion |
|
Credit Acceptance Corporation
NASDAQ:CACC
|
USA | $7.18 Billion |
|
Vishal Mega Mart Ord Shs
NSE:VMM
|
India | Rs40.36 Billion |
|
NEXANS ADR EO 1
F:NXS0
|
Germany | €6.02 Billion |
|
Associated Banc-Corp
NYSE:ASB
|
USA | $40.60 Billion |
|
Air Canada
TO:AC
|
Canada | CA$30.37 Billion |
|
Motilal Oswal Financial Services Limited
NSE:MOTILALOFS
|
India | Rs305.16 Billion |
|
TMBThanachart Bank Public Company Limited
F:NVPJ
|
Germany | €1.46 Trillion |
Liability Composition Analysis (2000–2025)
This chart breaks down ICL Israel Chemicals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ICL Israel Chemicals Ltd (ICL) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ICL Israel Chemicals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ICL Israel Chemicals Ltd (2000–2025)
The table below shows the annual total liabilities of ICL Israel Chemicals Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA6.17 Billion ≈ $16.54 Million |
+15.67% |
| 2024-12-31 | ILA5.33 Billion ≈ $14.30 Million |
-4.58% |
| 2023-12-31 | ILA5.59 Billion ≈ $14.99 Million |
-7.40% |
| 2022-12-31 | ILA6.04 Billion ≈ $16.18 Million |
-4.84% |
| 2021-12-31 | ILA6.34 Billion ≈ $17.01 Million |
+13.77% |
| 2020-12-31 | ILA5.58 Billion ≈ $14.95 Million |
+9.08% |
| 2019-12-31 | ILA5.11 Billion ≈ $13.71 Million |
+5.75% |
| 2018-12-31 | ILA4.83 Billion ≈ $12.96 Million |
-16.42% |
| 2017-12-31 | ILA5.78 Billion ≈ $15.51 Million |
-1.85% |
| 2016-12-31 | ILA5.89 Billion ≈ $15.80 Million |
+0.07% |
| 2015-12-31 | ILA5.89 Billion ≈ $15.79 Million |
+10.13% |
| 2014-12-31 | ILA5.35 Billion ≈ $14.34 Million |
+24.51% |
| 2013-12-31 | ILA4.29 Billion ≈ $11.51 Million |
-1.20% |
| 2012-12-31 | ILA4.35 Billion ≈ $11.65 Million |
+4.03% |
| 2011-12-31 | ILA4.18 Billion ≈ $11.20 Million |
+11.51% |
| 2010-12-31 | ILA3.75 Billion ≈ $10.05 Million |
+20.37% |
| 2009-12-31 | ILA3.11 Billion ≈ $8.35 Million |
-3.54% |
| 2008-12-31 | ILA3.23 Billion ≈ $8.65 Million |
+16.40% |
| 2007-12-31 | ILA2.77 Billion ≈ $7.43 Million |
+48.06% |
| 2006-12-31 | ILA1.87 Billion ≈ $5.02 Million |
+2.68% |
| 2005-12-31 | ILA1.82 Billion ≈ $4.89 Million |
-0.78% |
| 2004-12-31 | ILA1.84 Billion ≈ $4.93 Million |
-9.70% |
| 2003-12-31 | ILA2.04 Billion ≈ $5.46 Million |
-3.94% |
| 2002-12-31 | ILA2.12 Billion ≈ $5.68 Million |
+0.08% |
| 2001-12-31 | ILA2.12 Billion ≈ $5.68 Million |
-10.92% |
| 2000-12-31 | ILA2.38 Billion ≈ $6.37 Million |
-- |
About ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various gr… Read more